Replies to post #370125 on NorthWest Biotherapeutics Inc (NWBO)

[marzan]

Nick, anderz doesn't apprise how big MRK will become once it acquires DcVax. Merck will be the first Trillion dollar market cap pharma in the world following the Amazon/Apple/sectors, and electric TSLAs. Merck knows this.

[tryn2]

Hey Nick... my thoughts are that Merck will offer 3x whatever the pps is after TLD... if it goes to $12 after presser and journal publication, Merck offers $36, if $15, then $45, if $20, then $60.... this assumes a deal is in place... if not, the price goes WAY up in a bidding war...

[anders2211]

Nick in your scenario 1 and 2 you are not incorporating the total O/S if ALL granted options and warrants were to be exercised. If that were the case the total o/s are 1.5 billion (a little less I believe but approx 1.5b)


Now what would a BP want to pay for NWBO? Many many posts have been dedicated to this subject. I believe that it is a max of 25B$. There are those here that claim that NWBO is on a path to be able to treat ALL solid tumors, but I do not believe that. I mean the science is there but not the trials. The near approval, for now, is ONLY for GBM. There are those that believe that after DCVAX L for GBM is approved that somehow NWBO then also is granted approval for solid tumors in let's say breast cancer. But that would be incredibly unfair to Gilead who just paid 21B $ for Immunomedics (granted approval to treat solid tumors for breast cancer). If The FDA would grant NWBO the BP buying NWBO, approval for tumors for breast cancer then there would be never-ending lawsuits by Gilead and I can already pick the winner and that is not NWBO the BP buying NWBO.

So for now GBM 4b$ worth in revenue...? 25B$ I think that's realistic divided by 1.5 = 18$ per share..
IMO